Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shopaax appears to have operated as an online seller of sexual-enhancement honey products rather than as a biotech, pharma, or healthcare R&D company. Public FDA records identify Shopaax.com in Newark, Delaware as the seller of products including Royal Honey for Him and Kingdom Honey Royal Honey VIP. In 2022, the FDA issued a warning letter to Shopaax.com and the company also recalled Kingdom Honey Royal Honey VIP after laboratory testing found undeclared sildenafil, the active ingredient in Viagra. Based on the available evidence, Shopaax was a direct-to-consumer e-commerce business with regulatory issues involving adulterated or misbranded products, not a life sciences innovator with a therapeutic pipeline. No evidence was found of drug discovery, clinical development, proprietary healthcare technology, or formal pharmaceutical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shopaax.